Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis.
OBJECTIVE
The inflammatory component of most human inflammatory chronic diseases implicates the production of proinflammatory cytokines. Tumor necrosis factor alpha (TNFalpha) and interleukin 1beta (IL1beta) seem to play an important role in ulcerative colitis (UC) in relevant experimental models. Moreover, antiTNF therapy seems promising experimentally and clinically. However, these cytokines, and TNFalpha more particularly, are hardly seen in vivo in such patients. The mediators of choice, correlated with disease activities or drug efficacy, remain unclear. To characterize in vivo the network of colonic cytokines in patients with UC, and the contribution of the various cytokines to disease activity we performed this study, using the colonic perfusion method.


METHODS
A 20-cm colon length was perfused. Perfusate samples were collected for cytokine determination by enzyme-linked immnoassays. Nineteen perfusions were performed in mild to moderate UC, including two successive perfusions in four patients. Six healthy control patients and four having Crohn's disease (CD) with rectal involvement were studied. Endoscopic score, leukocyte scintigraphy, and systemic markers of inflammation were simultaneously quantified.


RESULTS
Large amounts of IL1beta, TNFalpha, IL6, and IL8 were produced in UC patients with a highly significant correlation between TNFalpha, IL1beta and IL8 two by two. Multivariate factorial analysis indicated that IL1beta showed the best correlation with disease activity. Locally produced IL6 was strongly associated with circulating platelet counts. Moreover, production of inflammatory cytokines was associated with similar variations of disease activity in the four patients with two successive perfusions performed. The level of inflammatory cytokines in CD was lower than in UC; TNFalpha, IL1beta, and IL6 were not found in any control patients.


CONCLUSIONS
UC appears to be a chronic inflammatory disease characterized by high production of all four proinflammatory cytokines (IL1beta, TNFalpha, IL6, and IL8). These results suggest that colonic perfusion may be a suitable method to evaluate the local anticytokine properties of new drugs, in correlation with disease activity and systemic markers of inflammation.
Guimbaud
R
R
Service d'Hépatogastroentérologie et Laboratoire de recherche en Pathologie Digestive, Hôpital Cochin et Université René Descartes, Paris, France.
Bertrand
V
V
Chauvelot-Moachon
L
L
Quartier
G
G
Vidon
N
N
Giroud
J P
JP
Couturier
D
D
Chaussade
S
S
D000328:Adult; D003093:Colitis, Ulcerative / Q000378:metabolism / Q000503:physiopathology*; D003106:Colon / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism / Q000502:physiology*; D008297:Male; D015999:Multivariate Analysis; D010477:Perfusion; D009195:Peroxidase / Q000378:metabolism
D016207:Cytokines; D018836:Inflammation Mediators; D009195:Peroxidase